Curanex Pharmaceuticals Inc. CURX 深 沪
已收盘 02-06 16:00:00 美东时间
0.276
+0.008
+2.99%
华盛通- 最 高0.29
- 今 开0.275
- 成交量 12.69万股
- 最 低 0.262
- 昨 收 0.268
- 总市值 782.21万
- 52周最高 9.1796
- 市盈率 静 --
- 换手率 0.45%
- 52周最低 0.262
- 委 比 -25.98%
- 总股本 2834.08万
- 历史最高 9.1796
- 量 比 0.36
- 振 幅 10.45%
- 历史最低 0.262
- 每 手 1
- 风险率 2.23%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Curanex Pharmaceuticals Faces Nasdaq Delisting Warning
The latest update is out from Curanex Pharmaceuticals Inc. ( ($CURX) ). On Nove...
2025-11-07 02:57
Curanex Pharmaceuticals Inc. Engages Strategic Investor Relations to Enhance Investor Communications and Engagement
Curanex Pharmaceuticals has partnered with Strategic Investor Relations to enhance its visibility and communication with investors. The company focuses on developing botanical drugs for inflammatory diseases, with its lead candidate, Phyto-N, targeting ulcerative colitis. Curanex aims to advance its pipeline, supported by decades of clinical evidence, and improve shareholder value through effective investor engagement.
2025-10-22 11:00
Curanex Pharmaceuticals Issues Shares Post-IPO
Curanex Pharmaceuticals Inc. ( ($CURX) ) has issued an update. On September 25,...
2025-09-30 04:18
Why Bullish Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
Shares of Bullish (NYSE:BLSH) rose sharply in pre-market trading after the comp...
2025-09-18 17:09
Curanex Pharmaceuticals Boosts IPO Proceeds with Share Sale
An announcement from Curanex Pharmaceuticals Inc. ( ($CURX) ) is now available....
2025-09-13 03:17
Curanex Pharmaceuticals Inc. Announces Exercise of the Over-Allotment Option by Underwriters
Curanex Pharmaceuticals Inc. announced that Dominari Securities LLC, the lead underwriter for its IPO, has fully exercised the over-allotment option, purchasing an additional 562,500 shares at $4.00 per share. This brings the total gross proceeds to $17.25 million from the issuance of 4.3125 million shares. The company plans to advance its lead botanical drug candidate, Phyto-N, for treating inflammatory diseases, with a focus on moderate to seve...
2025-09-12 18:46
美股机会日报 | 大摩改变立场！预计美联储今年降息2次；回声星通信一度飙升逾80%
大摩改变立场！预计美联储今年降息2次；高盛：美股市场夏季行情即将结束；回声星通信一度飙升逾80%，传AT&T将收购频谱牌照>>
2025-08-26 19:47
Curanex Pharmaceuticals announces pricing of its initial public offering
Curanex Pharmaceuticals (NASDAQ:CURX) announced on Tuesday the pricing of its initial public offering of 3.75 million shares of common stock at a public offering price of $4.00 per share, for gross pr...
2025-08-26 19:39
Curanex Pharmaceuticals Inc. Announces Pricing of its Initial Public Offering
Curanex Pharmaceuticals Inc. announced the pricing of its initial public offering of 3,750,000 shares at $4.00 per share, raising $15 million. The funds will be used to develop its lead candidate, Phyto-N, for treating inflammatory diseases like ulcerative colitis. The shares will begin trading on the Nasdaq Capital Market on August 26 under the ticker symbol "CURX." The Offering includes an option for underwriters to purchase up to an additional...
2025-08-26 11:30
华盛早报 | 对美联储“开刀”！特朗普火速罢免理事库克；拼多多高管称亮眼净利润“不可持续”
对美联储“开刀”！特朗普火速罢免理事库克；拼多多绩后股价巨震，管理层称亮眼净利润“不可持续”；双登股份今日上市，一手中签率0.06%>>
2025-08-26 08:18
